Brief: Abvc Biopharma Inc - Dr. Howard Doong, The Chief Executive Officer (“CEO”) Of Co Notified The Company Of His Resignation, Effective June 21, 2023
23/06/2023 21:34
ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA INC - DR. HOWARD DOONG, THE CHIEF EXECUTIVE
OFFICER (“CEO”) OF CO NOTIFIED THE COMPANY OF HIS RESIGNATION,
EFFECTIVE JUNE 21, 2023
* ABVC BIOPHARMA INC - BOARD OF DIRECTORS APPOINTED UTTAM
YASHWANT
PATIL TO REPLACE DOONG AS COMPANY'S CEO
Source text for Eikon: ID:
Further company coverage: ABVC.O
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon
Brief: Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements
Brief: ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma
Brief: ABVC Biopharma Secures $200,000 In First Cash Licensing Payment From Oncology Products Partner